The Drug-Induced Respiratory Disease Website and App

XII.r

XII - Cardiovascular involvement / toxicity

Heart failure (biventricular, congestive)

Last update 17/06/2026

Can occur as a consequence of several pulmonary obliterative vasculopathies. Cardiac tamponade may mimic this condition. See under VI

Causative drugs

16

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.g
I.w
I.z
III.d
IV.a
V.d
V.m
IX.j
X.b
X.s
XVII.b
XVII.e
XVII.f
XVII.g
XVII.z
XVII.aa
II.a
II.b
II.p
III.a
IV.c
V.u
VI.b
VIII.c
VIII.w
IX.a
IX.d
X.f
X.u
X.w
XI.b
XI.bc
XII.f
XII.h
XII.m
XII.w
XII.ag
XII.ah
XV.z
XIX.d
XXIV.i
XXIV.j
XXVII.a
I.e
I.f
I.u
I.v
I.aa
I.ad
I.aj
I.ax
II.d
III.m
IV.n
IV.ab
V.a
V.i
V.s
VII.a
IX.ab
IX.ac
X.a
X.d
X.e
X.g
X.h
X.j
X.k
X.m
X.am
X.aw
X.ay
X.bi
XI.u
XI.ac
XI.aq
XI.ar
XI.au
XII.c
XII.d
XII.e
XII.g
XII.s
XII.ai
XII.ax
XII.ba
XV.a
XV.b
XV.c
XV.d
XV.e
XV.f
XV.l
XV.v
XV.ba
XV.ca
XV.co
XV.cp
XVI.k
XVI.v
XVI.w
XVI.bh
XVI.bm
XVI.bt
XVII.q
XIX.a
XIX.c
I.d
I.m
I.o
I.y
III.l
IV.j
IV.k
IV.t
IV.y
IV.ac
IV.ad
IV.al
VII.e
VIII.q
VIII.t
IX.r
X.c
X.ah
X.an
X.ax
XI.d
XI.k
XV.x
XV.bb
XV.cw
XVI.b
XVI.e
XVI.z
XVI.ai
XVII.o
XIX.b
Loading more…